| In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000 | 603 | 2000 |
| Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery S Chakrabarti, V Mautner, H Osman, KE Collingham, CD Fegan, ... Blood, The Journal of the American Society of Hematology 100 (5), 1619-1627, 2002 | 491 | 2002 |
| High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution S Chakrabarti, S Mackinnon, R Chopra, PD Kottaridis, K Peggs, ... Blood, The Journal of the American Society of Hematology 99 (12), 4357-4363, 2002 | 427 | 2002 |
| Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen R Chakraverty, K Peggs, R Chopra, DW Milligan, PD Kottaridis, ... Blood, The Journal of the American Society of Hematology 99 (3), 1071-1078, 2002 | 400 | 2002 |
| Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease PA Cane, BG Van Den Hoogen, S Chakrabarti, CD Fegan, A Osterhaus Bone marrow transplantation 31 (4), 309-310, 2003 | 191 | 2003 |
| Viral disease prevention after hematopoietic cell transplantation J Zaia, L Baden, MJ Boeckh, S Chakrabarti, H Einsele, P Ljungman, ... Bone marrow transplantation 44 (8), 471-482, 2009 | 184 | 2009 |
| Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance S Chakrabarti, D Pillay, D Ratcliffe, PA Cane, KE Collingham, DW Milligan Journal of Infectious Diseases 181 (6), 2055-2058, 2000 | 142 | 2000 |
| Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality S Chakrabarti, A Lees, SG Jones, DW Milligan Bone marrow transplantation 26 (8), 871-876, 2000 | 134 | 2000 |
| Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy S Chakrabarti, KE Collingham, CD Fegan, DW Milligan Bone Marrow Transplantation 23 (11), 1209-1211, 1999 | 114 | 1999 |
| Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management S Chakrabarti, DW Milligan, PAH Moss, V Mautner Leukemia & lymphoma 45 (5), 873-885, 2004 | 112 | 2004 |
| Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab I Avivi, S Chakrabarti, DW Milligan, H Waldmann, G Hale, H Osman, ... Biology of Blood and Marrow Transplantation 10 (3), 186-194, 2004 | 103 | 2004 |
| Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? S Chakrabarti, KE Collingham, CD Fegan, D Pillay, DW Milligan Bone marrow transplantation 26 (3), 305-307, 2000 | 100 | 2000 |
| Respiratory virus infections in transplant recipients after reduced‐intensity conditioning with Campath‐1H: high incidence but low mortality S Chakrabarti, I Avivi, S Mackinnon, K Ward, PD Kottaridis, H Osman, ... British journal of haematology 119 (4), 1125-1132, 2002 | 90 | 2002 |
| EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning JM Cohen, N Cooper, S Chakrabarti, K Thomson, S Samarasinghe, ... Leukemia & lymphoma 48 (2), 256-269, 2007 | 83 | 2007 |
| T‐cell depletion with Campath‐1H ‘in the bag’for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft‐versus‐host disease … S Chakrabarti, D MacDonald, G Hale, K Holder, V Turner, H Czarnecka, ... British journal of haematology 121 (1), 109-118, 2003 | 75 | 2003 |
| Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation S Chakrabarti, DW Milligan, D Pillay, S Mackinnon, K Holder, N Kaur, ... Blood 102 (3), 839-842, 2003 | 73 | 2003 |
| Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy S Chakrabarti, KE Collingham, K Holder, S Oyaide, D Pillay, DW Milligan Clinical infectious diseases 31 (6), 1516-1518, 2000 | 72 | 2000 |
| Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning … SR Jaiswal, S Zaman, A Chakrabarti, S Sen, S Mukherjee, S Bhargava, ... Biology of Blood and Marrow Transplantation 22 (10), 1867-1873, 2016 | 66 | 2016 |
| Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and … SR Jaiswal, A Chakrabarti, S Chatterjee, S Bhargava, K Ray, P O'Donnell, ... Biology of Blood and Marrow Transplantation 22 (3), 499-504, 2016 | 66 | 2016 |
| In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Cytotherapy 3 (3), 197-201, 2001 | 63 | 2001 |
